News about "conventional systemic HS therapy"

Novartis Receives Positive CHMP Opinion for Cosentyx in Adolescent Hidradenitis Suppurativa in Europe

Novartis Receives Positive CHMP Opinion for Cosentyx in Adolescent Hidradenitis Suppurativa in Europe

Novartis advances Cosentyx towards a potential new indication for adolescent hidradenitis suppurativa following a positive CHMP opinion, with a final European Commission decision expected within approximately two months.

Conventional Systemic HS Therapy | 16/11/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members